Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 17, 2020
Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods
Natalia Kunst, Edward C F Wilson, David Glynn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 12, 2021
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey
Joanna C Thorn, Charlotte F Davies, Sara T Brookes, et al.
Trials
|
October 15, 2025
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trial
Toby J L Humphrey, Fergus J Caskey, David C Wheeler, et al.
Plos Medicine
|
July 24, 2020
Effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among UK adolescents: A cluster randomised controlled trial
Kirsten Corder, Stephen J Sharp, Stephanie T Jong, et al.
Plos Medicine
|
March 7, 2020
Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England: The VBI randomised controlled trial
Wendy Hardeman, Joanna Mitchell, Sally Pears, et al.
Pharmacoeconomics
|
June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial
Edward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.
Pharmacoeconomics
|
May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial
Edward C F Wilson, David Price, Stanley D Musgrave, et al.
The New England Journal of Medicine
|
May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapy
David Price, Stanley D Musgrave, Lee Shepstone, et al.
BMJ (Clinical Research Ed.)
|
December 8, 2021
Multifactorial falls prevention programme compared with usual care in UK care homes for older people: multicentre cluster randomised controlled trial with economic evaluation
Pip A Logan, Jane C Horne, John R F Gladman, et al.
Health Technology Assessment (Winchester, England)
|
June 2, 2025
Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods study
Jehan N Karim, Helen Campbell, Pranav Pandya, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 17, 2020
Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods
Natalia Kunst, Edward C F Wilson, David Glynn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 12, 2021
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey
Joanna C Thorn, Charlotte F Davies, Sara T Brookes, et al.
Trials
|
October 15, 2025
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trial
Toby J L Humphrey, Fergus J Caskey, David C Wheeler, et al.
Plos Medicine
|
July 24, 2020
Effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among UK adolescents: A cluster randomised controlled trial
Kirsten Corder, Stephen J Sharp, Stephanie T Jong, et al.
Plos Medicine
|
March 7, 2020
Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England: The VBI randomised controlled trial
Wendy Hardeman, Joanna Mitchell, Sally Pears, et al.
Pharmacoeconomics
|
June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial
Edward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.
Pharmacoeconomics
|
May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial
Edward C F Wilson, David Price, Stanley D Musgrave, et al.
The New England Journal of Medicine
|
May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapy
David Price, Stanley D Musgrave, Lee Shepstone, et al.
BMJ (Clinical Research Ed.)
|
December 8, 2021
Multifactorial falls prevention programme compared with usual care in UK care homes for older people: multicentre cluster randomised controlled trial with economic evaluation
Pip A Logan, Jane C Horne, John R F Gladman, et al.
Health Technology Assessment (Winchester, England)
|
June 2, 2025
Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods study
Jehan N Karim, Helen Campbell, Pranav Pandya, et al.
Page
of 11